Public Employees Retirement Association of Colorado’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
Other funds holding CRSP
AIM
OAG
GP
SOCM
Public Employees Retirement Association of Colorado's CRSP Position: Q2 2026 in Review
Public Employees Retirement Association of Colorado held its CRISPR Therapeutics (CRSP) position steady in Q2 2026 at 8,961 shares worth $489K. The position accounts for ﹤0.01% of the portfolio, ranked #1035.
Public Employees Retirement Association of Colorado first reported a position in CRSP in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.19M in Q3 2022. 521 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.
- Public Employees Retirement Association of Colorado held 8,961 shares of CRISPR Therapeutics worth $489K as of Q2 2026.
- Public Employees Retirement Association of Colorado left its CRISPR Therapeutics share count unchanged in Q2 2026.
- CRISPR Therapeutics made up ﹤0.01% of Public Employees Retirement Association of Colorado's portfolio in Q2 2026, its #1035 holding.
- Public Employees Retirement Association of Colorado first reported a position in CRISPR Therapeutics in Q2 2020 and has held it in 25 quarters since.
- Public Employees Retirement Association of Colorado's CRISPR Therapeutics position peaked at $1.19M in Q3 2022.
- 521 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.
Based on Public Employees Retirement Association of Colorado's 13F filing for Q2 2026, filed 11 Aug 2026.